Click here to get full coverage on Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Daytona Beach News-Journal

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events  Daytona Beach News-Journal

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Daytona Beach News-Journal

Click here to get full coverage on Acurx Pharma (NASDAQ: ACXP) ends quarter with $5.9M cash; R&D spend $0.4M - Stock Titan

Acurx Pharma (NASDAQ: ACXP) ends quarter with $5.9M cash; R&D spend $0.4M  Stock Titan

Acurx Pharma (NASDAQ: ACXP) ends quarter with $5.9M cash; R&D spend $0.4M - Stock Titan

Click here to get full coverage on ACXP’s Steady Climb: New Developments? - timothysykes.com

ACXP’s Steady Climb: New Developments?  timothysykes.com

ACXP’s Steady Climb: New Developments? - timothysykes.com

Click here to get full coverage on New Analyst Forecast: $ACXP Given $31.0 Price Target | ACXP Stock News - Quiver Quantitative

New Analyst Forecast: $ACXP Given $31.0 Price Target | ACXP Stock News  Quiver Quantitative

New Analyst Forecast: $ACXP Given $31.0 Price Target | ACXP Stock News - Quiver Quantitative

Click here to get full coverage on Acurx Pharmaceuticals, Inc. (ACXP): Insider Were Buying In Q1 2025 - Yahoo Finance

Acurx Pharmaceuticals, Inc. (ACXP): Insider Were Buying In Q1 2025  Yahoo Finance

Acurx Pharmaceuticals, Inc. (ACXP): Insider Were Buying In Q1 2025 - Yahoo Finance

Click here to get full coverage on Why Is Acurx Pharmaceuticals Stock (ACXP) Up 250% Today? - TipRanks

Why Is Acurx Pharmaceuticals Stock (ACXP) Up 250% Today?  TipRanks

Why Is Acurx Pharmaceuticals Stock (ACXP) Up 250% Today? - TipRanks

Click here to get full coverage on Pharma Boom: Acurx on the Rise - StocksToTrade

Pharma Boom: Acurx on the Rise  StocksToTrade

Pharma Boom: Acurx on the Rise - StocksToTrade

Click here to get full coverage on New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television - The Herald-Mail

New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television  The Herald-Mail

New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television - The Herald-Mail

Click here to get full coverage on Acurx Announces Phase 3-Ready Ibezapolstat Data at IDWeek 2025 | ACXP Stock News - Stock Titan

Acurx Announces Phase 3-Ready Ibezapolstat Data at IDWeek 2025 | ACXP Stock News  Stock Titan

Acurx Announces Phase 3-Ready Ibezapolstat Data at IDWeek 2025 | ACXP Stock News - Stock Titan

Click here to get full coverage on Why Are Pharmaceutical Stocks XBIO, UPC, XTLB, & ACXP Up Today? - TipRanks

Why Are Pharmaceutical Stocks XBIO, UPC, XTLB, & ACXP Up Today?  TipRanks

Why Are Pharmaceutical Stocks XBIO, UPC, XTLB, & ACXP Up Today? - TipRanks

Click here to get full coverage on Acurx Pharmaceuticals, Inc. Announces Reverse Stock Split - Yahoo Finance

Acurx Pharmaceuticals, Inc. Announces Reverse Stock Split  Yahoo Finance

Acurx Pharmaceuticals, Inc. Announces Reverse Stock Split - Yahoo Finance

Click here to get full coverage on Acurx Pharmaceuticals (NASDAQ: ACXP) sets Nov 12 call on Q3 2025 results, business update - Stock Titan

Acurx Pharmaceuticals (NASDAQ: ACXP) sets Nov 12 call on Q3 2025 results, business update  Stock Titan

Acurx Pharmaceuticals (NASDAQ: ACXP) sets Nov 12 call on Q3 2025 results, business update - Stock Titan

Click here to get full coverage on Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors - Stock Titan

Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors  Stock Titan

Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors - Stock Titan

Click here to get full coverage on 20,000 Children Affected Annually: Acurx's New Antibiotic Gets Key EMA Support for C. difficile Treatment - Stock Titan

20,000 Children Affected Annually: Acurx's New Antibiotic Gets Key EMA Support for C. difficile Treatment  Stock Titan

20,000 Children Affected Annually: Acurx's New Antibiotic Gets Key EMA Support for C. difficile Treatment - Stock Titan

Click here to get full coverage on Acurx (NASDAQ: ACXP) announces Nature Communications study on ibezapolstat binding PolC - Stock Titan

Acurx (NASDAQ: ACXP) announces Nature Communications study on ibezapolstat binding PolC  Stock Titan

Acurx (NASDAQ: ACXP) announces Nature Communications study on ibezapolstat binding PolC - Stock Titan

Click here to get full coverage on Biotech Acurx Pharmaceuticals Secures Future on Nasdaq by Meeting Critical $1 Bid, $2.5M Equity Rules - Stock Titan

Biotech Acurx Pharmaceuticals Secures Future on Nasdaq by Meeting Critical $1 Bid, $2.5M Equity Rules  Stock Titan

Biotech Acurx Pharmaceuticals Secures Future on Nasdaq by Meeting Critical $1 Bid, $2.5M Equity Rules - Stock Titan

Click here to get full coverage on Biotech Acurx Pharmaceuticals Raises $2.67M in Strategic Warrant Exercise - New Warrants Issued at $0.425 - Stock Titan

Biotech Acurx Pharmaceuticals Raises $2.67M in Strategic Warrant Exercise - New Warrants Issued at $0.425  Stock Titan

Biotech Acurx Pharmaceuticals Raises $2.67M in Strategic Warrant Exercise - New Warrants Issued at $0.425 - Stock Titan

Click here to get full coverage on Acurx Pharmaceuticals (ACXP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Nasdaq

Acurx Pharmaceuticals (ACXP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now  Nasdaq

Acurx Pharmaceuticals (ACXP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Nasdaq

Click here to get full coverage on Acurx Pharmaceuticals stock maintains Buy rating at H.C. Wainwright - Investing.com

Acurx Pharmaceuticals stock maintains Buy rating at H.C. Wainwright  Investing.com

Acurx Pharmaceuticals stock maintains Buy rating at H.C. Wainwright - Investing.com

Click here to get full coverage on Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga

Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket  Benzinga

Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga

Click here to get full coverage on Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know - Nasdaq

Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know  Nasdaq

Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know - Nasdaq

Click here to get full coverage on Acurx Pharmaceuticals stock price target raised to $31 from $8 at H.C. Wainwright - Investing.com

Acurx Pharmaceuticals stock price target raised to $31 from $8 at H.C. Wainwright  Investing.com

Acurx Pharmaceuticals stock price target raised to $31 from $8 at H.C. Wainwright - Investing.com

Click here to get full coverage on Breakthrough: New Antibiotic Achieves 94% Cure Rate Against C. Difficile, Outperforms Standard Treatment - Stock Titan

Breakthrough: New Antibiotic Achieves 94% Cure Rate Against C. Difficile, Outperforms Standard Treatment  Stock Titan

Breakthrough: New Antibiotic Achieves 94% Cure Rate Against C. Difficile, Outperforms Standard Treatment - Stock Titan

Click here to get full coverage on Acurx Pharmaceuticals granted Australian patent for antibiotics - Investing.com

Acurx Pharmaceuticals granted Australian patent for antibiotics  Investing.com

Acurx Pharmaceuticals granted Australian patent for antibiotics - Investing.com

Click here to get full coverage on Acurx Approves 1-for-20 Reverse Stock Split To Regain Nasdaq Compliance - Nasdaq

Acurx Approves 1-for-20 Reverse Stock Split To Regain Nasdaq Compliance  Nasdaq

Acurx Approves 1-for-20 Reverse Stock Split To Regain Nasdaq Compliance - Nasdaq

Click here to get full coverage on New to The Street to Broadcast Nationwide on Bloomberg TV Tonight at 6:30 PM EST Featuring Roadzen, Spartan Equipment, XION, Metaterra, and YY Group - The Olympian

New to The Street to Broadcast Nationwide on Bloomberg TV Tonight at 6:30 PM EST Featuring Roadzen, Spartan Equipment, XION, Metaterra, and YY Group  The Olympian

New to The Street to Broadcast Nationwide on Bloomberg TV Tonight at 6:30 PM EST Featuring Roadzen, Spartan Equipment, XION, Metaterra, and YY Group - The Olympian

Click here to get full coverage on Acurx Pharmaceuticals Announces Reverse Stock Split - TipRanks

Acurx Pharmaceuticals Announces Reverse Stock Split  TipRanks

Acurx Pharmaceuticals Announces Reverse Stock Split - TipRanks

Click here to get full coverage on Acurx Pharmaceuticals’ Earnings Call: Achievements Amid Challenges - TipRanks

Acurx Pharmaceuticals’ Earnings Call: Achievements Amid Challenges  TipRanks

Acurx Pharmaceuticals’ Earnings Call: Achievements Amid Challenges - TipRanks

Click here to get full coverage on Acurx Pharmaceuticals Shareholders Approve Key Issuance Plans - TipRanks

Acurx Pharmaceuticals Shareholders Approve Key Issuance Plans  TipRanks

Acurx Pharmaceuticals Shareholders Approve Key Issuance Plans - TipRanks

Click here to get full coverage on Earnings call transcript: Acurx Pharmaceuticals Q2 2025 misses EPS forecast - Investing.com

Earnings call transcript: Acurx Pharmaceuticals Q2 2025 misses EPS forecast  Investing.com

Earnings call transcript: Acurx Pharmaceuticals Q2 2025 misses EPS forecast - Investing.com

Click here to get full coverage on US Stocks Lower; Retail Sales Decline In May - Benzinga

US Stocks Lower; Retail Sales Decline In May  Benzinga

US Stocks Lower; Retail Sales Decline In May - Benzinga

Click here to get full coverage on Acurx Pharmaceuticals Reports Q3 2025 Financial Results - TipRanks

Acurx Pharmaceuticals Reports Q3 2025 Financial Results  TipRanks

Acurx Pharmaceuticals Reports Q3 2025 Financial Results - TipRanks

Click here to get full coverage on MAGA Stocks Undercard: MYSE, XBIO, ATON, ACXP, RDZN - Innovators - openPR.com

MAGA Stocks Undercard: MYSE, XBIO, ATON, ACXP, RDZN - Innovators  openPR.com

MAGA Stocks Undercard: MYSE, XBIO, ATON, ACXP, RDZN - Innovators - openPR.com

Click here to get full coverage on Acurx's ibezapolstat shows microbiome-sparing properties in trials By Investing.com - Investing.com Nigeria

Acurx's ibezapolstat shows microbiome-sparing properties in trials By Investing.com  Investing.com Nigeria

Acurx's ibezapolstat shows microbiome-sparing properties in trials By Investing.com - Investing.com Nigeria

Click here to get full coverage on Crude Oil Rises Sharply; Jabil Earnings Top Views - Benzinga

Crude Oil Rises Sharply; Jabil Earnings Top Views  Benzinga

Crude Oil Rises Sharply; Jabil Earnings Top Views - Benzinga

Click here to get full coverage on New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group - Idaho Statesman

New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group  Idaho Statesman

New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group - Idaho Statesman

Click here to get full coverage on New to The Street to Broadcast Saturday, September 27th Featuring NeOnc Pharma $NTHI and Other Innovative Companies - Miami Herald

New to The Street to Broadcast Saturday, September 27th Featuring NeOnc Pharma $NTHI and Other Innovative Companies  Miami Herald

New to The Street to Broadcast Saturday, September 27th Featuring NeOnc Pharma $NTHI and Other Innovative Companies - Miami Herald

Click here to get full coverage on Morning Market Movers: PMAX, STI, GWH, ACON See Big Swings - RTTNews

Morning Market Movers: PMAX, STI, GWH, ACON See Big Swings  RTTNews

Morning Market Movers: PMAX, STI, GWH, ACON See Big Swings - RTTNews

Click here to get full coverage on New to The Street to Broadcast Nationwide on Bloomberg Tonight at 6:30 PM EST - ACCESS Newswire

New to The Street to Broadcast Nationwide on Bloomberg Tonight at 6:30 PM EST  ACCESS Newswire

New to The Street to Broadcast Nationwide on Bloomberg Tonight at 6:30 PM EST - ACCESS Newswire

Click here to get full coverage on We're A Little Worried About Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Rate - Yahoo Finance

We're A Little Worried About Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Rate  Yahoo Finance

We're A Little Worried About Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Rate - Yahoo Finance

Click here to get full coverage on We Think Acurx Pharmaceuticals (NASDAQ:ACXP) Needs To Drive Business Growth Carefully - Yahoo Finance

We Think Acurx Pharmaceuticals (NASDAQ:ACXP) Needs To Drive Business Growth Carefully  Yahoo Finance

We Think Acurx Pharmaceuticals (NASDAQ:ACXP) Needs To Drive Business Growth Carefully - Yahoo Finance

Click here to get full coverage on Acurx gains EMA support for ibezapolstat Phase 3 trial - Investing.com

Acurx gains EMA support for ibezapolstat Phase 3 trial  Investing.com

Acurx gains EMA support for ibezapolstat Phase 3 trial - Investing.com

Click here to get full coverage on Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy's playbook - CNBC

Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy's playbook  CNBC

Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy's playbook - CNBC

Click here to get full coverage on ACXP Stock Price and Chart — NASDAQ:ACXP - TradingView

ACXP Stock Price and Chart — NASDAQ:ACXP  TradingView

ACXP Stock Price and Chart — NASDAQ:ACXP - TradingView

Click here to get full coverage on ACXP - Acurx Pharmaceuticals Inc Latest Stock News & Market Updates - Stock Titan

ACXP - Acurx Pharmaceuticals Inc Latest Stock News & Market Updates  Stock Titan

ACXP - Acurx Pharmaceuticals Inc Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Acurx Sell-Off Presents Opportunity Before Upcoming Data Release - Seeking Alpha

Acurx Sell-Off Presents Opportunity Before Upcoming Data Release  Seeking Alpha

Acurx Sell-Off Presents Opportunity Before Upcoming Data Release - Seeking Alpha

Click here to get full coverage on Here's Why We're Watching Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Situation - Yahoo Finance

Here's Why We're Watching Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Situation  Yahoo Finance

Here's Why We're Watching Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Situation - Yahoo Finance

Click here to get full coverage on Acurx Pharmaceuticals (ACXP) Stock Price, Quote, News & History - Benzinga

Acurx Pharmaceuticals (ACXP) Stock Price, Quote, News & History  Benzinga

Acurx Pharmaceuticals (ACXP) Stock Price, Quote, News & History - Benzinga

Click here to get full coverage on Acurx Pharmaceuticals Joins the Antimicrobials Working Group - PR Newswire

Acurx Pharmaceuticals Joins the Antimicrobials Working Group  PR Newswire

Acurx Pharmaceuticals Joins the Antimicrobials Working Group - PR Newswire

Click here to get full coverage on New to The Street Announces its Five Business Guest Interviews, Episode 533, Airs on the FOX Business Network on Monday, November 27, 2023, at 10:30 PM PT - Yahoo Finance

New to The Street Announces its Five Business Guest Interviews, Episode 533, Airs on the FOX Business Network on Monday, November 27, 2023, at 10:30 PM PT  Yahoo Finance

New to The Street Announces its Five Business Guest Interviews, Episode 533, Airs on the FOX Business Network on Monday, November 27, 2023, at 10:30 PM PT - Yahoo Finance

Click here to get full coverage on 90% Plunge to 1000% Upside? Acurx Pharmaceuticals (ACXP) Stock Sees EMA Boost & Bold Analyst Predictions - ts2.tech

90% Plunge to 1000% Upside? Acurx Pharmaceuticals (ACXP) Stock Sees EMA Boost & Bold Analyst Predictions  ts2.tech

ACXP

Price Chart

Key Statistics

Technicals

About ACXP

Latest News

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Daytona Beach News-Journal

Acurx Pharma (NASDAQ: ACXP) ends quarter with $5.9M cash; R&D spend $0.4M - Stock Titan

ACXP’s Steady Climb: New Developments? - timothysykes.com

Advanced Charts

Top Gainers

Top Losers